CRVS vs. MKA.L
CRVS (Corvus Pharmaceuticals, Inc.) and MKA.L (Mkango Resources Ltd) are both stocks. CRVS operates in Biotechnology (Healthcare), while MKA.L operates in Other Industrial Metals & Mining (Basic Materials). Over the past 5 years, CRVS returned 31.93%/yr vs 5.07%/yr for MKA.L. At a 0.03 correlation, their price movements are largely independent.
Performance
CRVS vs. MKA.L - Performance Comparison
Loading charts...
Different Trading Currencies
CRVS is traded in USD, while MKA.L is traded in GBp. To make them comparable, the MKA.L values have been converted to USD using the latest available exchange rates.
Returns By Period
In the year-to-date period, CRVS achieves a 44.81% return, which is significantly higher than MKA.L's -10.47% return.
CRVS
- 1D
- 0.27%
- 1M
- -28.30%
- YTD
- 44.81%
- 6M
- 30.26%
- 1Y
- 185.17%
- 3Y*
- 46.04%
- 5Y*
- 31.93%
- 10Y*
- -1.39%
MKA.L
- 1D
- 2.49%
- 1M
- -7.63%
- YTD
- -10.47%
- 6M
- -15.90%
- 1Y
- 147.26%
- 3Y*
- 60.60%
- 5Y*
- 5.07%
- 10Y*
- —
CRVS vs. MKA.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CRVS Corvus Pharmaceuticals, Inc. | 44.81% | 43.93% | 203.98% | 107.06% | -64.73% | -32.30% | -34.56% | 48.23% | -64.58% | -27.55% |
MKA.L Mkango Resources Ltd | -10.47% | 529.04% | -32.02% | -1.17% | -64.71% | 75.54% | 109.72% | 4.01% | 11.91% | 144.31% |
Correlation
The correlation between CRVS and MKA.L is 0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.03 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.04 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.02 |
Correlation (All Time) Calculated using the full available price history since Jun 16, 2016 | 0.03 |
Fundamentals
CRVS:
$1.00B
MKA.L:
£146.26M
CRVS:
-$0.53
MKA.L:
-£0.04
CRVS:
$0.00
MKA.L:
£50.78K
CRVS:
-$26.00K
MKA.L:
-£544.15K
CRVS:
-$47.43M
MKA.L:
-£17.87M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CRVS vs. MKA.L — Risk / Return Rank
CRVS
MKA.L
CRVS vs. MKA.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Corvus Pharmaceuticals, Inc. (CRVS) and Mkango Resources Ltd (MKA.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CRVS | MKA.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.51 | ||
| Sortino ratioReturn per unit of downside risk | +1.68 | ||
| Omega ratioGain probability vs. loss probability | 1.48 | 1.28 | +0.19 |
| Calmar ratioReturn relative to maximum drawdown | 3.30 | 2.84 | +0.46 |
| Martin ratioReturn relative to average drawdown | 7.42 | 5.91 | +1.51 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| CRVS | MKA.L | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.03 | 1.54 | -0.51 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.24 | 0.07 | +0.18 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.01 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.02 | 0.27 | -0.29 |
Drawdowns
CRVS vs. MKA.L - Drawdown Comparison
The maximum CRVS drawdown since its inception was -96.97%, which is greater than MKA.L's maximum drawdown of -89.22%. Use the drawdown chart below to compare losses from any high point for CRVS and MKA.L.
Loading charts...
Drawdown Indicators
| CRVS | MKA.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.97% | -89.22% | -7.75% |
Max Drawdown (1Y)Largest decline over 1 year | -56.43% | -51.55% | -4.88% |
Max Drawdown (3Y)Largest decline over 3 years | -70.50% | -66.46% | -4.04% |
Max Drawdown (5Y)Largest decline over 5 years | -92.40% | -89.22% | -3.18% |
Max Drawdown (10Y)Largest decline over 10 years | -96.97% | — | — |
Current DrawdownCurrent decline from peak | -56.31% | -39.03% | -17.28% |
Average DrawdownAverage peak-to-trough decline | -69.32% | -45.46% | -23.86% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 25.07% | 24.81% | +0.26% |
Volatility
CRVS vs. MKA.L - Volatility Comparison
Corvus Pharmaceuticals, Inc. (CRVS) has a higher volatility of 23.70% compared to Mkango Resources Ltd (MKA.L) at 22.35%. This indicates that CRVS's price experiences larger fluctuations and is considered to be riskier than MKA.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CRVS | MKA.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 23.70% | 22.35% | +1.35% |
Volatility (6M)Calculated over the trailing 6-month period | 111.87% | 48.60% | +63.27% |
Volatility (1Y)Calculated over the trailing 1-year period | 181.10% | 95.35% | +85.75% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 131.06% | 77.87% | +53.19% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 111.16% | 96.62% | +14.54% |
Dividends
CRVS vs. MKA.L - Dividend Comparison
Neither CRVS nor MKA.L has paid dividends to shareholders.
Financials
CRVS vs. MKA.L - Financials Comparison
This section allows you to compare key financial metrics between Corvus Pharmaceuticals, Inc. and Mkango Resources Ltd. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
CRVS and MKA.L have a correlation of 0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for CRVS and MKA.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer